By the end of 2020, and through to 2022, around 50% of the remaining value of the fund was accounted for by the fund’s equity stake in Rutherford Health.
Erbyn diwedd 2020, a hyd at 2022, roedd tua 50% o weddill gwerth y gronfa yn cael ei gyfrif gan gyfran ecwiti’r gronfa yn Rutherford Health.